Analytical Chemistry and Stability Testing of Treatment Drugs for Substance Use Disorders Tender

Procurement Summary

Country : USA

Summary : Analytical Chemistry and Stability Testing of Treatment Drugs for Substance Use Disorders

Deadline : 30 Jun 2023

Other Information

Notice Type : Tender

TOT Ref.No.: 84100113

Document Ref. No. : 75N95023R00057UR

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

DESCRIPTION:

The National Institute on Drug Abuse (NIDA) is seeking Capability Statements from Other Than Small Business (OTSB) organizations to provide the Government support for analytical chemistry and stability testing of treatment drugs for substance use disorders.



This is a SOURCES SOUGHT NOTICE. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified business sources; and (2) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. The established NAICS code is 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). The U.S. Small Business Administration establishes a size standard for 541715 as 1, 000 employees or less.

BACKGROUND INFORMATION AND OBJECTIVE:

Drug development to improve the prevention and treatment of substance use disorders is a major mission of the National Institute on Drug Abuse (NIDA). The Institute provides investigational drugs to investigators for use in preclinical toxicology evaluations, pharmacological studies and clinical trials. The investigational drugs include both bulk drug substances (e.g., Almitrine, AZD2207, Cannabidiol, Nalmefene, Naloxone, etc.) and dosage forms (e.g., Buprenorphine sublingual tablets, Cannabidiol capsules, Lorcarserin capsules, Dronabinol capsules, etc.). The Government acquires these drugs from private industries, Government contractors/grantees or independent investigators. The Government has been performing quality control tests to ensure acceptable identity, strength, quality and purity of the investigational drugs before distributing...
Active Contract Opportunity
Notice ID : 75N95023R00057UR
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office : NATIONAL INSTITUTES OF HEALTH NIDA
General Information
Contract Opportunity Type: Sources Sought (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Jun 08, 2023 08:45 pm EDT
Original Response Date: Jun 30, 2023 04:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Jul 15, 2023
Initiative: None

Classification
Original Set Aside:
Product Service Code:
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance: Bethesda, MD 20892 USA

Documents

 Tender Notice